These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 7905143)

  • 1. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.
    Lancet; 1994 Feb; 343(8893):311-22. PubMed ID: 7905143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
    Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection factors for the use of thrombolytic treatment in acute myocardial infarction: a population based study of current practice in the United Kingdom. The European Secondary Prevention Study Group.
    Ketley D; Woods KL
    Br Heart J; 1995 Sep; 74(3):224-8. PubMed ID: 7547014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombolytic therapy: pre- and post-GISSI-2, ISIS-3, and GUSTO-1.
    Hennekens CH
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I15-7. PubMed ID: 8156657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of thrombolytic treatments on the mortality of myocardial infarction. Characteristics of large-scale trials, main results].
    Slama M; Cohen-Solal A; Spriet A
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():27-33. PubMed ID: 2512885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke.
    Wardlaw JM; Warlow CP; Counsell C
    Lancet; 1997 Aug; 350(9078):607-14. PubMed ID: 9288042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.
    Yusuf S; Collins R; Peto R; Furberg C; Stampfer MJ; Goldhaber SZ; Hennekens CH
    Eur Heart J; 1985 Jul; 6(7):556-85. PubMed ID: 3899654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis after acute myocardial infarction. Who should be added to inclusion criteria?
    Figueredo VM; Amidon TM; Wolfe CL
    Postgrad Med; 1994 Dec; 96(8):30-4, 37-40. PubMed ID: 7991476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy in acute myocardial infarction.
    Paspa PA; Movahed A
    Am Fam Physician; 1992 Feb; 45(2):640-8. PubMed ID: 1739049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy.
    Wong CK; Gao W; Stewart RA; van Pelt N; French JK; Aylward PE; White HD;
    Circulation; 2006 Aug; 114(8):783-9. PubMed ID: 16908761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic treatment in suspected acute myocardial infarction--use and risks in clinical practice.
    Beermann B; von Bahr C; Sundström A
    Eur J Clin Pharmacol; 1997; 52(3):179-82. PubMed ID: 9218923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.
    Held PH; Teo KK; Yusuf S
    Circulation; 1990 Nov; 82(5):1668-74. PubMed ID: 2146038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis in acute myocardial infarction.
    Holmberg SR
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolysis after acute myocardial infarction.
    Nee PA
    J Accid Emerg Med; 1997 Jan; 14(1):2-9. PubMed ID: 9023613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.